药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Amifampridine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Amifampridine.
19-Nor-4-androstenedione
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Dexchlorpheniramine maleate.
19-Nor-4-androstenedione
Benidipine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Benidipine.
19-Nor-4-androstenedione
Melperone
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Melperone.
19-Nor-4-androstenedione
Butriptyline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Butriptyline.
19-Nor-4-androstenedione
Eperisone
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Eperisone.
19-Nor-4-androstenedione
Fendiline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Fendiline.
19-Nor-4-androstenedione
Indenolol
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Indenolol.
19-Nor-4-androstenedione
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Bedaquiline.
19-Nor-4-androstenedione
Antazoline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Antazoline.
19-Nor-4-androstenedione
Nilvadipine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Nilvadipine.
19-Nor-4-androstenedione
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Nemonoxacin.
19-Nor-4-androstenedione
Telavancin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Telavancin.
19-Nor-4-androstenedione
Tucidinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Tucidinostat.
19-Nor-4-androstenedione
Tedisamil
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Tedisamil.
19-Nor-4-androstenedione
Garenoxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Garenoxacin.
19-Nor-4-androstenedione
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Technetium Tc-99m ciprofloxacin.
19-Nor-4-androstenedione
Pracinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Pracinostat.
19-Nor-4-androstenedione
Azimilide
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Azimilide.
19-Nor-4-androstenedione
Fluspirilene
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Fluspirilene.